VMD
Y Dược phẩm Vimedimex ·HOSE ·2025Q1
● Maintaining
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2025Q1 basis, VMD has not accelerated revenue, but profitability is improving more visibly — margins have been expanding consistently over multiple periods. Notably, most of the profit comes from non-core sources — this needs careful evaluation before concluding on growth quality.
| Metric | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 241.3 | 398.5 | 237.7 | 258.2 | 354.5 | 591.6 | 754.3 | 1,079.9 | 1,115.7 | 1,613.0 | 1,772.3 | 1,818.9 |
| Growth | -39% | +68% | -8% | -27% | -40% | -22% | -30% | -3% | -31% | -9% | -3% | — |
| Net Income | 3.9 | 14.3 | 5.3 | 2.7 | 2.8 | 6.7 | 5.4 | 3.7 | 3.9 | 18.7 | 9.5 | 2.5 |
| Net Margin | 1.60% | 3.58% | 2.21% | 1.03% | 0.78% | 1.13% | 0.72% | 0.34% | 0.35% | 1.16% | 0.53% | 0.14% |
Drivers of VMD's profit
Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by better other profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE rose from 4.3% to 6.1% — mainly driven by net margin, despite asset turnover and leverage moving in the opposite direction.
Is the profit sustainable?
Margins improved (+1.6pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.
What is driving the margin?
Net margin expanded to 2.29%, rising 1.6pp. Core operating signals are improving as Gross margin rose 2.1pp are enough to offset pressure from SG&A / Revenue rose 2.9pp (in addition, Other profit / Revenue rose 3.0pp added support while Net financial result / Revenue fell 0.2pp remained a drag).
Most of the margin increase comes from non-core items — core operations have not kept pace, this is a margin expansion to watch carefully.
Profitability trend
TTM YoY · 2024Q1 -> 2025Q1
Watchpoints
Other income accounts for 98.5% of PBT and lifted net margin by 2.8pp — separate the operating contribution from this source.
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2024Q1 -> 2025Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 1.87x equity, with a net cash position equivalent to 0.32x equity.
Over the last 12 months, working capital released 167.7bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2024Q1 -> 2025Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 37.5 days versus the same period last year. The main moves came from DIO fell 4.0 days, DSO rose 50.4 days, and DPO rose 83.9 days.
Extended payment timing is the main driver — consider whether this trades off supplier relationships.
Watchpoints
DSO increased by +50.4 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2024Q1 -> 2025Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 118.7bn.
Leverage & Liquidity
Leverage warrants monitoring, with net debt / equity at -0.32x and interest coverage only at 0.06x.
Debt maturity and the cash buffer remain the two key areas to monitor.
Some leverage signals are missing, so the current read should be treated as contextual.
Watchpoints
Interest coverage is 0.06x, leaving limited room to absorb financing costs.
Leverage and liquidity trend
TTM YoY · 2024Q1 -> 2025Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 118.7bn in 2024, against investing cash flow of 4.1bn.
Post-investment cash flow was positive +122.8bn. Financing cash flow was negative +31.4bn.
CFO / net income was 8.02x.
After spending +2.7bn on fixed-asset investment, the business generated trailing free cash flow of +210.0bn.
Cash Conversion
TTM Cash Conversion · 2024Q1 -> 2025Q1
Investment Takeaway
The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 1.6 pp. The next item to monitor is the earnings mix, when non-core contribution is -2.5%. The main risk still sits in leverage and liquidity, with interest coverage at 0.06x.
Improvement: operating efficiency is getting better, with trailing-12M net margin at 2.29% after expanding 1.6pp versus the same period last year.
Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 8.02x. Even so, net financial result still accounts for -2.5% of PBT, so the earnings mix still needs monitoring.
Key risk: leverage and liquidity still require discipline, with interest coverage only at 0.06x.
Statement Data
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
|
Net Revenue
|
1,249.9 | 3,544.0 | 7,073.5 | 12,318.8 | 18,162.2 |
|
Cost of Goods Sold
|
1,130.9 | 3,255.8 | 6,528.7 | 0.0 | 0.0 |
|
Gross Profit
|
118.9 | 288.2 | 544.8 | 1,068.7 | 1,396.3 |
|
Financial Expenses
|
10.3 | 4.8 | 23.6 | -174.5 | -188.1 |
|
Selling Expenses
|
85.7 | 207.1 | 444.4 | -826.1 | -1,117.8 |
|
General and Administrative Expenses
|
27.7 | 43.1 | 68.2 | -90.1 | -92.2 |
|
Operating Profit
|
2.6 | 46.6 | 46.5 | 26.5 | 41.3 |
|
Profit Before Tax
|
30.6 | 43.6 | 47.4 | 28.2 | 50.4 |
|
Net Income
|
23.6 | 31.2 | 35.2 | 19.1 | 37.1 |
|
Profit Attributable to Parent
|
23.2 | 28.2 | 34.8 | 19.8 | 37.1 |
|
Earnings per Share
|
1,449.00 | 1,737.00 | 2,255.00 | -525.00 | 2,400.76 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.